SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-162736
Filing Date
2009-08-04
Accepted
2009-08-04 06:04:53
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 535593
2 EXCLUSIVE PATENT LICENSE AGREEMENT dex10321.htm EX-10.321 88728
3 AMENDED AND RESTATED DIRECTOR COMPENSATION dex10322.htm EX-10.322 14463
4 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER - SECTION 302 dex311.htm EX-31.1 6343
5 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER - SECTION 302 dex312.htm EX-31.2 6341
6 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER - SECTION 906 dex321.htm EX-32.1 4344
7 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER - SECTION 906 dex322.htm EX-32.2 4346
  Complete submission text file 0001193125-09-162736.txt   661571
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 09981589
SIC: 2834 Pharmaceutical Preparations